In pharmaceuticals, secondary packaging constitutes the packaging that does not come in direct contact with the dosage form. Pharma secondary packaging is becoming widely adopted and essential as they offer critical functionalities, such as, physical and barrier...
Capturing Value from Pharma M&A: Critical Considerations for Success
The pharmaceutical industry is one of the major sectors that is actively involved in huge mergers and acquisitions (M&A) deals, both in terms of the number of deals and the amount of money spent. Most companies in the sector, especially the big pharma consider...
Answering FAQs on Pharmaceutical Logistics
An overview of the global pharmaceutical logistics market Keeping pharmaceutical products undamaged and therapeutically effective during their journey to the market can often prove to be an arduous and complex task. Once outside the sterile manufacturing and packaging...
Identifying Key Regenerative Medicine Manufacturing Challenges
Regenerative medicines are currently the hive of innovation in modern science with far-reaching benefits for big pharma, healthcare systems, and patient outcomes. We can expect a rapid pace of development in the US regenerative medicine market over the next decade....
Enhancing Market Share by 33% for a Pharma Company – Pharmaceutical Market Access Strategy
Pharmaceutical Market Access Strategy With healthcare becoming a priority for governments in several countries, the pharmaceutical industry seems to have a bright future. However, due to the rising healthcare costs, payers are demanding insights into a new drug’s...
Winning in Emerging Markets: What Big Pharma Companies Must Do
Emerging markets are highly promising and offer a plethora of opportunities for pharmaceutical companies. As a result, there is an unprecedented increase in the number of companies in the life sciences industry that are turning to emerging markets such as Brazil,...
Finding the Future of Pharma Manufacturing – Strategies to Reduce Costs and Boost Efficiency
The growing rate of the aging population with significant unmet needs is creating a high demand for pharma manufacturing companies. However, pharma manufacturing companies are also facing headwinds from unattractive pricing and volume expansion across all regions,...